These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9575560)

  • 1. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
    Morrison DC
    Prog Clin Biol Res; 1998; 397():199-207. PubMed ID: 9575560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.
    Horn DL; Opal SM; Lomastro E
    Scand J Infect Dis Suppl; 1996; 101():9-13. PubMed ID: 9060045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
    Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis--the Wayne State University Symposium--part III. Bacteremia and endotoxemia: a discussion of their roles in the pathophysiology of gram-negative sepsis.
    Sibbald WJ
    Heart Lung; 1976; 5(5):765-71. PubMed ID: 823128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxemia and Gram-negative bacteremia as predictors of outcome in sepsis: a meta-analysis using ROC curves.
    Hurley JC
    J Endotoxin Res; 2003; 9(5):271-9. PubMed ID: 14577843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxemia induced by antibiotic therapy: a mechanism for adrenal corticosteroid protection in gram-negative sepsis.
    Johnston CA; Greisman SE
    Trans Assoc Am Physicians; 1984; 97():172-81. PubMed ID: 6398946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-induced release of endotoxin: a reappraisal.
    Hurley JC
    Clin Infect Dis; 1992 Nov; 15(5):840-54. PubMed ID: 1445982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
    Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock.
    Periti P; Mazzei T
    Int J Antimicrob Agents; 1999 Jul; 12(2):97-105. PubMed ID: 10418753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin release after antibiotic treatment and its potential pathogenetic role in coagulative disorders of patients with gram-negative sepsis.
    Miragliotta G
    J Chemother; 1991 Jan; 3 Suppl 1():69-72. PubMed ID: 12041790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of the pathogenesis of gram-negative shock.
    Waage A; Brandtzaeg P; Espevik T; Halstensen A
    Infect Dis Clin North Am; 1991 Dec; 5(4):781-91. PubMed ID: 1783767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the endotoxin assay in post surgical patients.
    Büller HR; ten Cate JW; Sturk A; Thomas LL
    Prog Clin Biol Res; 1985; 189():405-17. PubMed ID: 4048215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based treatment of sepsis.
    Brandenburg K; Andrä J; Garidel P; Gutsmann T
    Appl Microbiol Biotechnol; 2011 May; 90(3):799-808. PubMed ID: 21369803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology and treatment of gram-negative sepsis.
    DiPiro JT
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S6-10. PubMed ID: 2275478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
    Roger T; Glauser MP; Calandra T
    J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.